Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04541225 |
|
Recruitment Status :
Terminated
(Sponsor decision)
First Posted : September 9, 2020
Last Update Posted : July 14, 2023
|
Sponsor:
Nuvation Bio Inc.
Information provided by (Responsible Party):
Nuvation Bio Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | August 31, 2022 |
| Actual Study Completion Date : | August 31, 2022 |